These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 32992152)

  • 1. Head and neck cancer patient-derived xenograft models - A systematic review.
    Schuch LF; Silveira FM; Wagner VP; Borgato GB; Rocha GZ; Castilho RM; Vargas PA; Martins MD
    Crit Rev Oncol Hematol; 2020 Nov; 155():103087. PubMed ID: 32992152
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumor grafts derived from patients with head and neck squamous carcinoma authentically maintain the molecular and histologic characteristics of human cancers.
    Peng S; Creighton CJ; Zhang Y; Sen B; Mazumdar T; Myers JN; Lai SY; Woolfson A; Lorenzi MV; Bell D; Williams MD; Johnson FM
    J Transl Med; 2013 Aug; 11():198. PubMed ID: 23981300
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Patient derived xenografts as models for head and neck cancer.
    Nitschinsk K; Idris A; McMillan N
    Cancer Lett; 2018 Oct; 434():114-119. PubMed ID: 30031118
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Patient-Derived Xenograft Models in Cervical Cancer: A Systematic Review.
    Tanaka T; Nishie R; Ueda S; Miyamoto S; Hashida S; Konishi H; Terada S; Kogata Y; Sasaki H; Tsunetoh S; Taniguchi K; Komura K; Ohmichi M
    Int J Mol Sci; 2021 Aug; 22(17):. PubMed ID: 34502278
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Patient-derived xenograft (PDX) tumors increase growth rate with time.
    Pearson AT; Finkel KA; Warner KA; Nör F; Tice D; Martins MD; Jackson TL; Nör JE
    Oncotarget; 2016 Feb; 7(7):7993-8005. PubMed ID: 26783960
    [TBL] [Abstract][Full Text] [Related]  

  • 6. IL-6 Inhibition With MEDI5117 Decreases The Fraction of Head and Neck Cancer Stem Cells and Prevents Tumor Recurrence.
    Finkel KA; Warner KA; Kerk S; Bradford CR; McLean SA; Prince ME; Zhong H; Hurt EM; Hollingsworth RE; Wicha MS; Tice DA; Nör JE
    Neoplasia; 2016 May; 18(5):273-281. PubMed ID: 27237319
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Establishment and Characterization of Patient-Derived Xenograft Models of Anaplastic Thyroid Carcinoma and Head and Neck Squamous Cell Carcinoma.
    Wu M; Liu Y; Zhao Y; Zhang Y; Huang L; Du Q; Zhang T; Zhong Z; Luo H; Xiao K
    J Vis Exp; 2023 Jun; (196):. PubMed ID: 37335092
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Establishment of a patient-derived xenograft model and cell line of malignant transformation of mature cystic teratoma of the ovary.
    Tamauchi S; Suzuki S; Xuboya C; Yoshihara M; Yoshida K; Ikeda Y; Yoshikawa N; Kajiyama H; Kikkawa F
    J Obstet Gynaecol Res; 2021 Feb; 47(2):713-719. PubMed ID: 33300248
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Application and development of patient-derived tumor xenograft model in translational medicine of tumor].
    Wang Z; Zhu Z
    Zhonghua Wei Chang Wai Ke Za Zhi; 2017 May; 20(5):596-600. PubMed ID: 28534338
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeting of Head and Neck Cancer by Radioiodinated CLR1404 in Murine Xenograft Tumor Models with Partial Volume Corrected Theranostic Dosimetry.
    Marsh IR; Li C; Grudzinski J; Jeffery J; Longhurst C; Adam DP; Hernandez R; Weichert JP; Harari PM; Bednarz BP
    Cancer Biother Radiopharm; 2023 Sep; 38(7):458-467. PubMed ID: 37022739
    [No Abstract]   [Full Text] [Related]  

  • 11. Patient-Derived Bladder Cancer Xenografts.
    Bernardo C; Santos LL
    Methods Mol Biol; 2018; 1655():169-175. PubMed ID: 28889386
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Xenografts derived from patients with head and neck cancer recapitulate patient tumour properties.
    Makita H; Endo K; Kasahara Y; Nakata A; Moriyama-Kita M; Ishikawa K; Ueno T; Nakanishi Y; Kondo S; Wakisaka N; Gotoh N; Yoshizaki T
    Oncol Lett; 2021 May; 21(5):385. PubMed ID: 33777208
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Establishment and characterization of a non-gestational choriocarcinoma patient-derived xenograft model.
    Oda Y; Niimi K; Yoshida K; Tamauchi S; Yokoi A; Yasui Y; Nishiko Y; Shibata M; Shimizu Y; Yoshihara M; Ikeda Y; Yoshikawa N; Nishino K; Yamamoto E; Kajiyama H
    BMC Cancer; 2023 Nov; 23(1):1103. PubMed ID: 37957624
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeting acid ceramidase sensitises head and neck cancer to cisplatin.
    Roh JL; Park JY; Kim EH; Jang HJ
    Eur J Cancer; 2016 Jan; 52():163-72. PubMed ID: 26687835
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comprehensively characterized large panel of head and neck cancer patient-derived xenografts identifies the mTOR inhibitor everolimus as potential new treatment option.
    Klinghammer K; Raguse JD; Plath T; Albers AE; Joehrens K; Zakarneh A; Brzezicha B; Wulf-Goldenberg A; Keilholz U; Hoffmann J; Fichtner I
    Int J Cancer; 2015 Jun; 136(12):2940-8. PubMed ID: 25404014
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Knowledge and practice of patient-derived xenograft models in leukemia].
    Kato I
    Rinsho Ketsueki; 2022; 63(9):1335-1343. PubMed ID: 36198560
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Establishment and characterization of patient-derived head and neck cancer models from surgical specimens and endoscopic biopsies.
    Strüder D; Momper T; Irmscher N; Krause M; Liese J; Schraven S; Zimpfer A; Zonnur S; Burmeister AS; Schneider B; Frerich B; Mlynski R; Große-Thie C; Junghanss C; Maletzki C
    J Exp Clin Cancer Res; 2021 Aug; 40(1):246. PubMed ID: 34362423
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Movember GAP1 PDX project: An international collection of serially transplantable prostate cancer patient-derived xenograft (PDX) models.
    Navone NM; van Weerden WM; Vessella RL; Williams ED; Wang Y; Isaacs JT; Nguyen HM; Culig Z; van der Pluijm G; Rentsch CA; Marques RB; de Ridder CMA; Bubendorf L; Thalmann GN; Brennen WN; Santer FR; Moser PL; Shepherd P; Efstathiou E; Xue H; Lin D; Buijs J; Bosse T; Collins A; Maitland N; Buzza M; Kouspou M; Achtman A; Taylor RA; Risbridger G; Corey E
    Prostate; 2018 Dec; 78(16):1262-1282. PubMed ID: 30073676
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Capturing colorectal cancer inter-tumor heterogeneity in patient-derived xenograft (PDX) models.
    Prasetyanti PR; van Hooff SR; van Herwaarden T; de Vries N; Kalloe K; Rodermond H; van Leersum R; de Jong JH; Franitza M; Nürnberg P; Todaro M; Stassi G; Medema JP
    Int J Cancer; 2019 Jan; 144(2):366-371. PubMed ID: 30151914
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Progress in building clinically relevant patient-derived tumor xenograft models for cancer research.
    Wang W; Li Y; Lin K; Wang X; Tu Y; Zhuo Z
    Animal Model Exp Med; 2023 Oct; 6(5):381-398. PubMed ID: 37679891
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.